这是一篇来自已证抗体库的有关人类 CXCL12的综述,是根据14篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CXCL12 抗体。
CXCL12 同义词: IRH; PBSF; SCYB12; SDF1; TLSF; TPAR1

安迪生物R&D
小鼠 单克隆(79014)
  • 抑制或激活实验; 人类; 25 ug/ml; 图 5a
安迪生物R&D CXCL12抗体(R&D Systems, MAB310)被用于被用于抑制或激活实验在人类样本上浓度为25 ug/ml (图 5a). BMC Pregnancy Childbirth (2020) ncbi
小鼠 单克隆(79018)
  • 免疫组化-石蜡切片; 人类; 10 ug/ml; 图 1
安迪生物R&D CXCL12抗体(R&D Systems, MAB350)被用于被用于免疫组化-石蜡切片在人类样本上浓度为10 ug/ml (图 1). BMC Pregnancy Childbirth (2020) ncbi
小鼠 单克隆(79014)
  • 免疫组化; 人类; 1:600; 图 6
安迪生物R&D CXCL12抗体(R&D Systems, MAB310)被用于被用于免疫组化在人类样本上浓度为1:600 (图 6). J Histochem Cytochem (2018) ncbi
小鼠 单克隆(79018)
  • 流式细胞仪; 小鼠; 1:10; 图 2h
安迪生物R&D CXCL12抗体(R&D Systems, IC350A)被用于被用于流式细胞仪在小鼠样本上浓度为1:10 (图 2h). Nat Cell Biol (2017) ncbi
小鼠 单克隆(79018)
  • 免疫组化-石蜡切片; 大鼠; 1:40; 图 st14
安迪生物R&D CXCL12抗体(R&D System??, MAB350)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:40 (图 st14). J Toxicol Pathol (2017) ncbi
小鼠 单克隆(79018)
  • 免疫组化-冰冻切片; 人类; 图 4
安迪生物R&D CXCL12抗体(R&D Systems, 79018)被用于被用于免疫组化-冰冻切片在人类样本上 (图 4). J Dermatol Sci (2017) ncbi
小鼠 单克隆(79018)
  • 流式细胞仪; 人类; 图 2d
安迪生物R&D CXCL12抗体(R&D Systems, 79018)被用于被用于流式细胞仪在人类样本上 (图 2d). Eur J Immunol (2017) ncbi
小鼠 单克隆(79014)
  • 抑制或激活实验; 小鼠; 图 4a
安迪生物R&D CXCL12抗体(R&D Systems, 79014)被用于被用于抑制或激活实验在小鼠样本上 (图 4a). Cancer Res (2016) ncbi
domestic goat 多克隆
  • 免疫组化; 人类; 1:100; 图 1
安迪生物R&D CXCL12抗体(R&D Systems , AF-310-NA)被用于被用于免疫组化在人类样本上浓度为1:100 (图 1). Int J Cancer (2016) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 人类; 1:200; 图 5d
艾博抗(上海)贸易有限公司 CXCL12抗体(Abcam, ab9797)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:200 (图 5d). J Histochem Cytochem (2018) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 1:200; 图 5b
艾博抗(上海)贸易有限公司 CXCL12抗体(Abcam, ab 9797)被用于被用于免疫组化在人类样本上浓度为1:200 (图 5b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 3
艾博抗(上海)贸易有限公司 CXCL12抗体(Abcam, ab9797)被用于被用于免疫印迹在小鼠样本上 (图 3). Oncogene (2016) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1d
赛默飞世尔 CXCL12抗体(Thermo Fisher Scientific, PA5-30603)被用于被用于免疫印迹在人类样本上 (图 1d). Urol Int (2017) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3d
赛信通(上海)生物试剂有限公司 CXCL12抗体(Cell Signaling, 3740)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3d). Biosci Rep (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 CXCL12抗体(Cell Signaling, 3740)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D32F9)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 CXCL12抗体(Cell Signaling Technology, 3530)被用于被用于免疫印迹在人类样本上浓度为1:1000. Mol Cell Biochem (2015) ncbi
文章列表
  1. Zheng J, Qu D, Wang C, Ding L, Zhou W. Involvement of CXCL12/CXCR4 in the motility of human first-trimester endometrial epithelial cells through an autocrine mechanism by activating PI3K/AKT signaling. BMC Pregnancy Childbirth. 2020;20:87 pubmed 出版商
  2. Li L, Du Z, Rong B, Zhao D, Wang A, Xu Y, et al. Foam cells promote atherosclerosis progression by releasing CXCL12. Biosci Rep. 2020;40: pubmed 出版商
  3. Hira V, Wormer J, Kakar H, Breznik B, van der Swaan B, Hulsbos R, et al. Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins. J Histochem Cytochem. 2018;66:155-173 pubmed 出版商
  4. Asada N, Kunisaki Y, Pierce H, Wang Z, Fernandez N, Birbrair A, et al. Differential cytokine contributions of perivascular haematopoietic stem cell niches. Nat Cell Biol. 2017;19:214-223 pubmed 出版商
  5. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed 出版商
  6. Ujiie I, Fujita Y, Nakayama C, Matsumura W, Suzuki S, Shinkuma S, et al. Altered balance of epidermis-related chemokines in epidermolysis bullosa. J Dermatol Sci. 2017;86:37-45 pubmed 出版商
  7. Pangrazzi L, Meryk A, Naismith E, Koziel R, Lair J, Krismer M, et al. "Inflamm-aging" influences immune cell survival factors in human bone marrow. Eur J Immunol. 2017;47:481-492 pubmed 出版商
  8. Schagdarsurengin U, Teuchert L, Hagenkötter C, Nesheim N, Dansranjavin T, Schuppe H, et al. Chronic Prostatitis Affects Male Reproductive Health and Is Associated with Systemic and Local Epigenetic Inactivation of C-X-C Motif Chemokine 12 Receptor C-X-C Chemokine Receptor Type 4. Urol Int. 2017;98:89-101 pubmed 出版商
  9. Dmitriev P, Kiseleva E, Kharchenko O, Ivashkin E, Pichugin A, Dessen P, et al. Dux4 controls migration of mesenchymal stem cells through the Cxcr4-Sdf1 axis. Oncotarget. 2016;7:65090-65108 pubmed 出版商
  10. Martinelli G, Olivari D, Re Cecconi A, Talamini L, Ottoboni L, Lecker S, et al. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia. Oncogene. 2016;35:6212-6222 pubmed 出版商
  11. Ananthula S, Sinha A, El Gassim M, Batth S, Marshall G, Gardner L, et al. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers. Oncotarget. 2016;7:20869-89 pubmed 出版商
  12. Kasagi Y, Harada Y, Morodomi Y, Iwai T, Saito S, Yoshida K, et al. Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrix-Directed Spheroid Formation. Cancer Res. 2016;76:347-57 pubmed 出版商
  13. Izumi D, Ishimoto T, Miyake K, Sugihara H, Eto K, Sawayama H, et al. CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer. Int J Cancer. 2016;138:1207-19 pubmed 出版商
  14. Zhang J, Zhao J, Bai Y, Huang L, Yu W, Li X. Effects of p75 neurotrophin receptor on regulating hypoxia-induced angiogenic factors in retinal pigment epithelial cells. Mol Cell Biochem. 2015;398:123-34 pubmed 出版商